These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 37258790)

  • 1. The Evolving Landscape of Potency Assays.
    Burns JS
    Adv Exp Med Biol; 2023; 1420():165-189. PubMed ID: 37258790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based therapeutic products: potency assay development and application.
    Basu J; Ludlow JW
    Regen Med; 2014; 9(4):497-512. PubMed ID: 25159066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Methods for ATMP Release.
    Radrizzani M; Soncin S; Lo Cicero V; Andriolo G; Bolis S; Turchetto L
    Methods Mol Biol; 2016; 1416():313-37. PubMed ID: 27236681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles.
    Gimona M; Brizzi MF; Choo ABH; Dominici M; Davidson SM; Grillari J; Hermann DM; Hill AF; de Kleijn D; Lai RC; Lai CP; Lim R; Monguió-Tortajada M; Muraca M; Ochiya T; Ortiz LA; Toh WS; Yi YW; Witwer KW; Giebel B; Lim SK
    Cytotherapy; 2021 May; 23(5):373-380. PubMed ID: 33934807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells.
    Wang L; Gong W; Wang S; Neuber B; Sellner L; Schubert ML; Hückelhoven-Krauss A; Kunz A; Gern U; Michels B; Hinkelbein M; Mechler S; Richter P; Müller-Tidow C; Schmitt M; Schmitt A
    Cytotherapy; 2019 May; 21(5):566-578. PubMed ID: 30910382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency Assay Development: A Keystone for Clinical Use.
    Torggler R; Margreiter E; Marksteiner R; Thurner M
    Adv Exp Med Biol; 2023; 1420():13-28. PubMed ID: 37258781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illustrative Potency Assay Examples from Approved Therapies.
    Torrents S; Grau-Vorster M; Vives J
    Adv Exp Med Biol; 2023; 1420():139-149. PubMed ID: 37258788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy.
    de Wolf C; van de Bovenkamp M; Hoefnagel M
    Cytotherapy; 2017 Jul; 19(7):784-797. PubMed ID: 28457740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical-scale expansion of mesenchymal stromal cells: a large banking experience.
    Lechanteur C; Briquet A; Giet O; Delloye O; Baudoux E; Beguin Y
    J Transl Med; 2016 May; 14(1):145. PubMed ID: 27207011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data.
    Martins JP; Santos JM; de Almeida JM; Filipe MA; de Almeida MV; Almeida SC; Água-Doce A; Varela A; Gilljam M; Stellan B; Pohl S; Dittmar K; Lindenmaier W; Alici E; Graça L; Cruz PE; Cruz HJ; Bárcia RN
    Stem Cell Res Ther; 2014 Jan; 5(1):9. PubMed ID: 24438697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Validation Strategy.
    Radrizzani M; Soncin S; Bolis S; Lo Cicero V; Andriolo G; Turchetto L
    Methods Mol Biol; 2016; 1416():339-56. PubMed ID: 27236682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Art of Stem Cell-Based Therapy.
    Burns JS
    Adv Exp Med Biol; 2023; 1420():1-12. PubMed ID: 37258780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency.
    Robb KP; Fitzgerald JC; Barry F; Viswanathan S
    Cytotherapy; 2019 Mar; 21(3):289-306. PubMed ID: 30528726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory perspective on in vitro potency assays for human dendritic cells used in anti-tumor immunotherapy.
    DE Wolf C; VAN DE Bovenkamp M; Hoefnagel M
    Cytotherapy; 2018 Nov; 20(11):1289-1308. PubMed ID: 30327247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes.
    Oja S; Kaartinen T; Ahti M; Korhonen M; Laitinen A; Nystedt J
    Front Immunol; 2019; 10():1627. PubMed ID: 31379832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency testing of cell and gene therapy products.
    Salmikangas P; Carlsson B; Klumb C; Reimer T; Thirstrup S
    Front Med (Lausanne); 2023; 10():1190016. PubMed ID: 37215709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Technologies for Potency Assay Measurement.
    Chinnadurai R
    Adv Exp Med Biol; 2023; 1420():81-95. PubMed ID: 37258785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Hypothermic Storage Fluids on Mesenchymal Stem Cell Stability: A Comprehensive Review and Personal Experience.
    Ścieżyńska A; Soszyńska M; Szpak P; Krześniak N; Malejczyk J; Kalaszczyńska I
    Cells; 2021 Apr; 10(5):. PubMed ID: 33925059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of Graphene Biosensors for Human Stem Cell Therapy Potency Assays.
    Amărandi RM; Becheru DF; Vlăsceanu GM; Ioniță M; Burns JS
    Biomed Res Int; 2018; 2018():1676851. PubMed ID: 30003089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.